Oscar Health, Inc. (NYSE:OSCR) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of Oscar Health, Inc. (NYSE:OSCR) have been given an average rating of “Moderate Buy” by the eight ratings firms that are currently covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $24.00.

A number of brokerages have commented on OSCR. Wells Fargo & Company boosted their target price on shares of Oscar Health from $24.00 to $27.00 and gave the stock an “overweight” rating in a report on Wednesday, June 12th. Piper Sandler reissued an “overweight” rating and set a $28.00 target price on shares of Oscar Health in a research report on Tuesday, September 10th. Finally, UBS Group initiated coverage on shares of Oscar Health in a report on Monday. They issued a “neutral” rating and a $23.00 price target on the stock.

Insider Transactions at Oscar Health

In related news, CFO Richard Scott Blackley sold 68,978 shares of the company’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $1,240,914.22. Following the transaction, the chief financial officer now directly owns 884,213 shares of the company’s stock, valued at $15,906,991.87. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Oscar Health news, CFO Richard Scott Blackley sold 68,978 shares of Oscar Health stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $1,240,914.22. Following the completion of the sale, the chief financial officer now directly owns 884,213 shares in the company, valued at approximately $15,906,991.87. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Mario Schlosser sold 3,198 shares of the stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the completion of the sale, the insider now owns 76,982 shares in the company, valued at $1,384,906.18. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 169,569 shares of company stock worth $3,007,069. Company insiders own 25.11% of the company’s stock.

Hedge Funds Weigh In On Oscar Health

Several institutional investors and hedge funds have recently modified their holdings of the stock. Symmetry Peak Management LLC purchased a new position in Oscar Health during the fourth quarter valued at approximately $488,000. Allspring Global Investments Holdings LLC purchased a new position in shares of Oscar Health during the 1st quarter valued at approximately $4,117,000. Assenagon Asset Management S.A. lifted its stake in shares of Oscar Health by 32.9% in the 2nd quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock valued at $32,368,000 after purchasing an additional 507,009 shares during the period. TD Asset Management Inc boosted its holdings in Oscar Health by 71.9% during the fourth quarter. TD Asset Management Inc now owns 195,600 shares of the company’s stock worth $1,790,000 after buying an additional 81,800 shares in the last quarter. Finally, First Light Asset Management LLC acquired a new stake in Oscar Health during the fourth quarter valued at $8,854,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Stock Performance

Shares of OSCR stock opened at $18.28 on Friday. The firm has a market cap of $4.34 billion, a price-to-earnings ratio of -45.70, a PEG ratio of 40.11 and a beta of 1.62. Oscar Health has a 52-week low of $4.72 and a 52-week high of $23.79. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.26. The company’s 50 day moving average is $18.98 and its 200 day moving average is $18.09.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Wednesday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. The business had revenue of $2.20 billion for the quarter, compared to the consensus estimate of $2.13 billion. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The business’s revenue was up 44.6% compared to the same quarter last year. During the same period last year, the business posted ($0.07) EPS. On average, sell-side analysts anticipate that Oscar Health will post 0.01 EPS for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.